TP53 and neoplasm: The striking similarities of tumour cells and adenovirus infected cells gave rise to the concept of using a mutant adenovirus to selectively eliminate tumour cells, which is based on the observation that in both, tumour cells and adenovirus infected cells, p53 – in its role as ‘guardian of the genome’ – is a major target for inactivation.